Fennec Pharmaceuticals (FENC) Gains from Investment Securities (2022 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Gains from Investment Securities came in at $1000.0 in Q2 2025, little changed on a QoQ basis from $1000.0 in Q1 2025.
Fennec Pharmaceuticals (FENC) Gains from Investment Securities (2022 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of Gains from Investment Securities data on file, last reported at $1000.0 in Q2 2025.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $1000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (down 97.53% YoY) and the FY2025 annual result came in at $2000.0, down 97.53% from the prior year.
- Gains from Investment Securities held at $1000.0 in Q2 2025, from $1000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $67000.0 in Q4 2024 to a low of -$4000.0 in Q4 2023.
- A 4-year average of $20000.0 and a median of $11000.0 in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities sank 106.9% — and 2024, when it jumped 1775.0%.
- Tracing FENC's Gains from Investment Securities over 4 years: stood at $58000.0 in 2022, then sank by 106.9% to -$4000.0 in 2023, then jumped by 1775.0% to $67000.0 in 2024, then sank by 98.51% to $1000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $1000.0 (Q2 2025), $1000.0 (Q1 2025), and $67000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Dec 31, 2022 | 58,000.00 |